0RK9

Alligator Bioscience Ab (0RK9)

Alligator Bioscience Ab

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:0RK9

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/04/01	15:20	PR Newswire (US)	Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences	LSE:0RK9	Alligator Bioscience Ab
2022/04/01	15:19	PR Newswire (US)	Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences	LSE:0RK9	Alligator Bioscience Ab
2022/03/23	17:07	PR Newswire (US)	Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg	LSE:0RK9	Alligator Bioscience Ab
2022/03/23	17:06	PR Newswire (US)	Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg	LSE:0RK9	Alligator Bioscience Ab
2022/02/11	16:23	PR Newswire (US)	Alligator Bioscience AB: Year End report January-December 2021	LSE:0RK9	Alligator Bioscience Ab
2022/02/11	16:22	PR Newswire (US)	Alligator Bioscience AB: Year End report January-December 2021	LSE:0RK9	Alligator Bioscience Ab
2022/02/01	17:16	PR Newswire (US)	Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer	LSE:0RK9	Alligator Bioscience Ab
2022/02/01	16:20	PR Newswire (US)	Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer	LSE:0RK9	Alligator Bioscience Ab
2022/01/19	16:42	PR Newswire (US)	Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty	LSE:0RK9	Alligator Bioscience Ab
2022/01/19	16:41	PR Newswire (US)	Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty	LSE:0RK9	Alligator Bioscience Ab
2022/01/18	16:19	PR Newswire (US)	Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported	LSE:0RK9	Alligator Bioscience Ab
2022/01/18	16:16	PR Newswire (US)	Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported	LSE:0RK9	Alligator Bioscience Ab
2021/12/16	16:41	PR Newswire (US)	Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability Data	LSE:0RK9	Alligator Bioscience Ab
2021/12/16	16:39	PR Newswire (US)	Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability Data	LSE:0RK9	Alligator Bioscience Ab
2021/12/15	22:37	PR Newswire (US)	Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature Communication	LSE:0RK9	Alligator Bioscience Ab
2021/12/15	22:36	PR Newswire (US)	Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature Communication	LSE:0RK9	Alligator Bioscience Ab
2021/11/09	01:54	PR Newswire (US)	Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam	LSE:0RK9	Alligator Bioscience Ab
2021/11/09	01:53	PR Newswire (US)	Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam	LSE:0RK9	Alligator Bioscience Ab
2021/11/09	00:59	PR Newswire (US)	Bulletin from the extraordinary general meeting in Alligator Bioscience AB	LSE:0RK9	Alligator Bioscience Ab
2021/11/09	00:57	PR Newswire (US)	Bulletin from the extraordinary general meeting in Alligator Bioscience AB	LSE:0RK9	Alligator Bioscience Ab
2021/10/21	15:45	PR Newswire (US)	Alligator Bioscience AB: Interim report January-September 2021	LSE:0RK9	Alligator Bioscience Ab
2021/10/21	15:41	PR Newswire (US)	Alligator Bioscience AB: Interim report January-September 2021	LSE:0RK9	Alligator Bioscience Ab
2021/10/07	15:25	PR Newswire (US)	Notice of extraordinary general meeting in Alligator Bioscience AB	LSE:0RK9	Alligator Bioscience Ab
2021/10/07	15:23	PR Newswire (US)	Notice of extraordinary general meeting in Alligator Bioscience AB	LSE:0RK9	Alligator Bioscience Ab
2021/09/02	19:17	PR Newswire (US)	Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline	LSE:0RK9	Alligator Bioscience Ab
2021/09/02	19:14	PR Newswire (US)	Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline	LSE:0RK9	Alligator Bioscience Ab
2021/09/02	17:33	PR Newswire (US)	Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination Therapy	LSE:0RK9	Alligator Bioscience Ab
2021/08/18	15:50	PR Newswire (US)	Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation	LSE:0RK9	Alligator Bioscience Ab
2021/08/18	15:49	PR Newswire (US)	Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation	LSE:0RK9	Alligator Bioscience Ab
2021/08/16	22:16	PR Newswire (US)	Alligator Bioscience Announces New Senior Director of Communications & Investor Relations	LSE:0RK9	Alligator Bioscience Ab